Tempus AI, Inc. (TEM)
NASDAQ: TEM · Real-Time Price · USD
68.02
+6.17 (9.98%)
Feb 5, 2025, 11:52 AM EST - Market open
Tempus AI Revenue
Tempus AI had revenue of $180.93M in the quarter ending September 30, 2024, with 32.98% growth. This brings the company's revenue in the last twelve months to $640.44M, up 32.13% year-over-year. In the year 2023, Tempus AI had annual revenue of $531.82M with 65.85% growth.
Revenue (ttm)
$640.44M
Revenue Growth
+32.13%
P/S Ratio
9.08
Revenue / Employee
$328,095
Employees
1,952
Market Cap
10.51B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 531.82M | 211.15M | 65.85% |
Dec 31, 2022 | 320.67M | 62.82M | 24.36% |
Dec 31, 2021 | 257.85M | 69.85M | 37.15% |
Dec 31, 2020 | 188.00M | 125.95M | 202.95% |
Dec 31, 2019 | 62.06M | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 400.28B |
Johnson & Johnson | 88.82B |
Merck & Co. | 63.17B |
AbbVie | 56.33B |
Novartis AG | 51.72B |
AstraZeneca | 51.21B |
Thermo Fisher Scientific | 42.88B |
Abbott Laboratories | 41.95B |
TEM News
- 1 hour ago - Tempus AI: In Vogue, But Better To Wait For Some Retracement - Seeking Alpha
- 1 day ago - Tempus AI stock price is not cheap: is it a good buy? - Invezz
- 1 day ago - Tempus Completes Acquisition of Ambry Genetics - Business Wire
- 8 days ago - Genialis Advances Biomarker Discovery to Reduce Risk in Cancer Drug Development Targeting DNA Damage Response Pathways - Business Wire
- 8 days ago - Tempus AI: Bringing The Promise Of AI To Healthcare - Seeking Alpha
- 9 days ago - What's Happening With Tempus AI (TEM) Stock? - Forbes
- 12 days ago - Tempus AI: Wait For A Cooldown - Seeking Alpha
- 13 days ago - Tempus AI's Flywheel Effect: Monetizing Data In Precision Medicine - Seeking Alpha